NEW YORK (GenomeWeb News) – Of the 33 firms that are included in the GenomeWeb Daily News Index of life science tools and molecular diagnostics makers, eight of those had stock price gains exceeding 100 percent for full-year 2009.

As was the case with tech stocks in general in the market, many of the firms in the Index had double-digit returns, with only six firms having a drop in their stock price compared to the close of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.